Similarly, a rat model of AAA showed that alogliptin attenuates aneurysm formation and aortic dilatation ratio via an antioxidative effect (reduction of ROS formation), and reduced MMP2 and MMP-9 expression levels in the aortic tissue (153). This evidence concerns the gene MMP2 and triple-A syndrome.